News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
260,580 Results
Type
Article (6267)
Company Profile (30)
Press Release (254283)
Multimedia
Podcasts (3)
Webinars (5)
Section
Business (88538)
Career Advice (475)
Deals (16605)
Drug Delivery (11)
Drug Development (21743)
Employer Resources (33)
FDA (4102)
Job Trends (4655)
News (131249)
Policy (8500)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (398)
Accelerated approval (14)
ADA (11)
Adcomms (4)
Allergies (28)
Alliances (16554)
ALS (63)
Alzheimer's disease (443)
Antibody-drug conjugate (ADC) (94)
Approvals (4289)
Artificial intelligence (177)
ASCO (59)
Autoimmune disease (81)
Automation (15)
Bankruptcy (108)
Best Places to Work (3476)
BIO (24)
Biosimilars (42)
Biotechnology (31)
Bladder cancer (52)
Brain cancer (21)
Breast cancer (195)
Cancer (1455)
Cardiovascular disease (115)
Career advice (408)
Career pathing (5)
CAR-T (87)
CDC (4)
Celiac Disease (1)
Cell therapy (237)
Cervical cancer (10)
Clinical research (19384)
Collaboration (574)
Compensation (495)
Complete response letters (14)
COVID-19 (478)
CRISPR (36)
C-suite (541)
Cystic fibrosis (32)
Data (2184)
Denatured (2)
Depression (34)
Dermatology (25)
Diabetes (126)
Diagnostics (2577)
Digital health (14)
Diversity (3)
Diversity, equity & inclusion (14)
Drug discovery (76)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (65)
Earnings (46175)
Editorial (5)
Employer branding (6)
Employer resources (34)
Events (43661)
Executive appointments (520)
FDA (5114)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (9)
Frontotemporal dementia (14)
Funding (504)
Gene editing (55)
Generative AI (9)
Gene therapy (136)
GLP-1 (187)
Government (552)
Guidances (213)
Healthcare (5789)
Hematology (55)
HIV (16)
Huntington's disease (8)
IgA nephropathy (26)
Immunology and inflammation (51)
Immuno-oncology (20)
Indications (40)
Infectious disease (527)
Inflammatory bowel disease (40)
Inflation Reduction Act (3)
Influenza (11)
Intellectual property (48)
Interviews (57)
IPO (8549)
IRA (3)
Job creations (1267)
Job search strategy (367)
JPM (4)
Kidney cancer (14)
Labor market (14)
Layoffs (119)
Leadership (7)
Legal (2687)
Liver cancer (22)
Longevity (9)
Lung cancer (159)
Lymphoma (101)
Machine learning (12)
Management (11)
Manufacturing (243)
Marketing (1)
MASH (66)
Medical device (4418)
Medtech (4464)
Mergers & acquisitions (8611)
Metabolic disorders (317)
mRNA (21)
Multiple sclerosis (30)
NASH (6)
Neurodegenerative disease (95)
Neuropsychiatric disorders (15)
Neuroscience (832)
NextGen: Class of 2026 (1825)
Non-profit (838)
Now hiring (7)
Obesity (125)
Opinion (38)
Ovarian cancer (47)
Pain (43)
Pancreatic cancer (89)
Parkinson's disease (81)
Partnered (12)
Patents (94)
Patient recruitment (168)
Peanut (6)
People (27889)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase 1 (5818)
Phase 2 (8599)
Phase 3 (6638)
Pipeline (3595)
Policy (25)
Postmarket research (660)
Preclinical (2353)
Press Release (67)
Prostate cancer (95)
Psychedelics (5)
Radiopharmaceuticals (155)
Rare diseases (268)
Real estate (2045)
Recruiting (9)
Regulatory (6446)
Reports (19)
Research institute (406)
Resumes & cover letters (69)
Rett syndrome (31)
RNA editing (7)
RSV (2)
Schizophrenia (71)
Series A (82)
Series B (74)
Service/supplier (2)
Sickle cell disease (21)
Special edition (1)
Spinal muscular atrophy (39)
Sponsored (8)
Startups (1157)
State (1)
Stomach cancer (1)
Supply chain (24)
Tariffs (7)
The Weekly (1)
Vaccines (130)
Venture capital (18)
Weight loss (43)
Women's health (15)
Worklife (1)
Date
Today (39)
Last 7 days (153)
Last 30 days (703)
Last 365 days (10212)
2026 (5323)
2025 (10304)
2024 (12484)
2023 (14819)
2022 (20769)
2021 (22144)
2020 (19963)
2019 (14526)
2018 (11181)
2017 (11072)
2016 (10210)
2015 (13401)
2014 (10518)
2013 (8470)
2012 (9181)
2011 (9561)
2010 (9335)
Location
Africa (203)
Alabama (20)
Alaska (2)
Arizona (93)
Arkansas (2)
Asia (12887)
Australia (1840)
California (4691)
Canada (2138)
China (247)
Colorado (188)
Connecticut (221)
Delaware (98)
Europe (28336)
Florida (737)
Georgia (101)
Idaho (25)
Illinois (241)
India (30)
Indiana (183)
Iowa (9)
Japan (260)
Kansas (43)
Kentucky (23)
Louisiana (12)
Maine (57)
Maryland (443)
Massachusetts (3833)
Michigan (154)
Minnesota (275)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (14)
Nevada (67)
New Hampshire (27)
New Jersey (1547)
New Mexico (8)
New York (1162)
North Carolina (645)
North Dakota (6)
Northern California (2514)
Ohio (148)
Oklahoma (9)
Oregon (7)
Pennsylvania (877)
Puerto Rico (4)
Rhode Island (20)
South America (315)
South Carolina (20)
Southern California (1738)
Tennessee (88)
Texas (746)
United States (17001)
Utah (151)
Vermont (1)
Virginia (111)
Washington D.C. (18)
Washington State (418)
West Virginia (2)
Wisconsin (89)
Wyoming (2)
260,580 Results for "zenith epigenetics corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Press Releases
Zenith Epigenetics Provides Update on ZEN-3694 NUT Carcinoma Program
April 9, 2026
·
5 min read
Press Releases
Zenith Capital Corp. Appoints Bryan Ede to Board of Directors
March 4, 2026
·
3 min read
Press Releases
FDA grants Zenith’s ZEN-3694 Fast Track Status
Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma
July 14, 2025
·
5 min read
Press Releases
Zenith Epigenetics’ ZEN-3694 Receives Orphan Drug Designation from FDA
October 27, 2025
·
6 min read
Press Releases
Infinite Epigenetics Acquires Tally Health to Accelerate the Future of Epigenetics-Driven Health and Longevity
April 29, 2026
·
5 min read
Press Releases
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026
·
4 min read
Press Releases
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis
March 12, 2026
·
5 min read
Zenith Epigenetics Proudly Supports Rare Disease Day
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694
February 29, 2024
·
5 min read
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a global leader in epigenetics, announced today it has entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of Zenith Epigenetics’ ZEN-3694 program.
October 26, 2023
·
7 min read
1 of 26,058
Next
